Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Menstrual cycle and zidovudine pharmacokinetics in HIV-infected women
I. Abdel-Hameed
, M. Ebid
, M. J. Shelton
, J. M. Adams
, J. A. Cordaro
, L. J. Gugino
, M. Maliszewski
, R. Colomaio
, R. G. Hewitt
, G. D. Morse
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Menstrual cycle and zidovudine pharmacokinetics in HIV-infected women'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Zidovudine
100%
Pharmacokinetics
100%
Menstrual Cycle
100%
HIV-infected Patients
100%
Life Cycle Stages
41%
Area under the Concentration-time Curve
25%
Inter-patient Variability
16%
Estradiol
16%
Plasma Concentration
16%
Luteal Phase
16%
Follicular Phase
16%
Hormonal Fluctuations
16%
Medical Center
8%
No Significant Difference
8%
CD4+
8%
CD8+
8%
Cell Count
8%
Immunodeficiency
8%
Medical History
8%
Estrogen
8%
Cortisol
8%
Exclusion Criteria
8%
HIV-1 Infection
8%
Inter-subject Variability
8%
Elimination Half-life
8%
Serum Concentration
8%
Pharmacokinetic Parameters
8%
Oral Dose
8%
Fasted State
8%
Negative Relationships
8%
Drug Administration
8%
Pharmacokinetic Profile
8%
Complete Blood Count
8%
Peak Plasma Concentration
8%
Plasma Drug Concentration
8%
Intra-variability
8%
Maximum Time
8%
Urinalysis
8%
Glucuronidation
8%
Erie
8%
Oestradiol Concentrations
8%
Oral Clearance
8%
Impact Plasma
8%
Fluctuating Concentrations
8%
HIV Seropositive
8%
Women with HIV
8%
Estradiol/progesterone
8%
Lymphocyte Profile
8%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Zidovudine
100%
Menstrual Cycle
100%
Diethylstilbestrol
16%
Immune Deficiency
8%
CD4 Lymphocyte Count
8%
Drug Concentration
8%
Blood Level
8%
Human Immunodeficiency Virus 1 Infection
8%
Hydrocortisone
8%
Blood Cell Count
8%
Progesterone
8%
Urinalysis
8%
Drug Administration
8%
CD8 Lymphocyte Count
8%
Estradiol Blood Level
8%
Pharmacokinetic Parameters
8%
Drug Blood Level
8%
Elimination Half-Life
8%
Oral Clearance
8%
Estrogen
8%
Medical History
8%
Glucuronidation
8%
Maximum Plasma Concentration
8%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Zidovudine
100%
Pharmacokinetics
100%
Diethylstilbestrol
25%
Elimination
16%
Hydrocortisone
8%
Immune Deficiency
8%
Drug Administration
8%
Progesterone
8%
CD8 Antigen
8%
Drug Concentration
8%
Pharmacokinetic Parameter
8%
Medical History
8%
Human Immunodeficiency Virus 1 Infection
8%
Buffalo
8%
Estrogen
8%